Aarti Pharma Q1 Net Profit Surges 65% to ₹76.1 Cr on Strong Revenue Growth

reported robust consolidated results for the quarter ended June 2026. Net profit rose 65% year-on-year to ₹761 million from ₹460 million in the corresponding quarter last year. Revenue grew 39% to ₹5.36 billion from ₹3.86 billion, while EBITDA increased to ₹1.36 billion from ₹952 million. The EBITDA margin expanded slightly to 25.40% from 24.66% year-on-year, reflecting improved operating performance and better realisations in the API and intermediates business.